Ohta Yuki, Hamaguchi Akemi, Ootaki Masanori, Watanabe Minoru, Takeba Yuko, Iiri Taroh, Matsumoto Naoki, Takenaga Mitsuko
Department of Pharmacology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Institute of Medical Science, St. Marianna University Graduate School of Medicine, Kawasaki, Kanagawa, Japan.
Cytotherapy. 2017 Jul;19(7):839-848. doi: 10.1016/j.jcyt.2017.04.002. Epub 2017 May 3.
Adipose tissue has therapeutic potential for spinal cord injury (SCI) because it contains multipotent cells known as adipose-derived stem/stromal cells (ASCs). In this study, we attempted intravenous ASC transplantation in rats with SCI to examine the effect on functional recovery.
ASCs (2.5 × 10) were intravenously infused into SCI rats, after which hindlimb motor function was evaluated. Distribution of transplanted ASCs was investigated and growth factor/cytokine levels were determined.
Intravenous transplantation of ASCs promoted the functional recovery in SCI rats and reduced the area of spinal cord cavitation. A distribution study revealed that ASCs gradually accumulated at the site of injury, but long-term survival of these cells was not achieved. Levels of growth factors increased only slightly in the spinal cord after ASC transplantation. Unexpectedly, cytokine-induced neutrophil chemoattractant (CINC)-1 showed a transient but substantial increase in the spinal cord tissue and blood of the ASC group. CINC-1 was secreted by ASCs in vitro, and the sponge implantation assay showed that CINC-1 and ASCs induced angiogenesis. CINC-1 promoted functional recovery in SCI rats, which was similar to the ASCs. Expression of glial cell line-derived neurotrophic factor was greater in the ASC group than in the CINC-1 group, although both promoted extracellular signal-regulated kinase (ERK)1/2 phosphorylation; Akt phosphorylation was enhanced in the spinal cord after ASC transplantation.
Our findings indicated that intravenously transplanted ASCs gradually accumulated in the injured spinal cord, where cytokines such as CINC-1 activated ERK1/2 and Akt, leading to functional recovery.
脂肪组织具有治疗脊髓损伤(SCI)的潜力,因为它含有多能细胞,即脂肪来源的干细胞/基质细胞(ASC)。在本研究中,我们尝试对脊髓损伤大鼠进行静脉注射ASC移植,以检查其对功能恢复的影响。
将2.5×10个ASC静脉注入脊髓损伤大鼠体内,之后评估后肢运动功能。研究移植ASC的分布情况,并测定生长因子/细胞因子水平。
静脉注射ASC可促进脊髓损伤大鼠的功能恢复,并减少脊髓空洞面积。分布研究显示,ASC逐渐在损伤部位积聚,但这些细胞未实现长期存活。ASC移植后,脊髓中生长因子水平仅略有升高。出乎意料的是,细胞因子诱导的中性粒细胞趋化因子(CINC)-1在ASC组的脊髓组织和血液中出现短暂但显著的升高。CINC-1在体外由ASC分泌,海绵植入试验表明CINC-1和ASC可诱导血管生成。CINC-1促进脊髓损伤大鼠的功能恢复,这与ASC相似。尽管两者均促进细胞外信号调节激酶(ERK)1/2磷酸化,但ASC组中胶质细胞源性神经营养因子的表达高于CINC-1组;ASC移植后脊髓中Akt磷酸化增强。
我们的研究结果表明,静脉注射的ASC逐渐积聚在受损脊髓中,在那里CINC-1等细胞因子激活ERK1/2和Akt,从而导致功能恢复。